Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Director/PDMR Shareholding

24 Oct 2022 16:15

RNS Number : 9232D
WANdisco Plc
24 October 2022
 

24 October 2022

 

WANdisco plc

 

("WANdisco" or the "Company")

 

Director's Dealing

 

The Board of WANdisco announces that it has received notification on 20 October 2022 that on 20 October 2022 Karl Monaghan, a Non-Executive Director of WANdisco, transferred a total of 8,785 WANdisco Ordinary Shares of 10p each ("Ordinary Shares) from his private holding into a separate ISA account for his wife (totaling 4,395 Ordinary Shares) and personal ISA (totaling 4,390 Ordinary Shares). The transfer of the 4,395 shares into Mr Monaghan's wife's ISA was transacted at a price of 454p sold from private holdings and purchased for 454.75p per Ordinary Share by the ISA, and the transfer of the 4,390 shares into Mr Monaghan's personal ISA was transacted at a price of 454.5p sold from private holdings and purchased for 455.3p per Ordinary Share by the ISA, representing 0.01% of the issued share capital of WANdisco.

 

Transfer of 4,395 WANdisco ordinary shares to Rosena Monaghan's ISA account

 

Transfer of 4,390 WANdisco ordinary shares to Karl Monaghan's personal ISA account

 

Following the transfer, Mr Monaghan and his wife's overall beneficial interest in WANdisco's shares remains unchanged.

 

Director

Total WANdisco shares 

% of WANdisco shares in issue beneficially held

Karl Monaghan

64,629

0.11%

 

 

The WANdisco shares referred to above are WANdisco's ordinary shares of ten pence each and the total number of shares in issue is 66,613,784 with each ordinary share carrying the right to one vote. The figure of 66,613,784 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the DTRs.

These details have been provided in accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014

 

For further information, please contact:

 

WANdisco plc

via FTI Consulting

David Richards, Chief Executive Officer and Chairman

Erik Miller, Chief Financial Officer

Kam Bansil, Investor Relations

 

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Tom Blundell

 

 

 

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Richard Short

 

 

Panmure Gordon (Joint Broker)

Erik Anderson / Alina Vaskina

+44 (0)20 7886 2500

 

 

About WANdisco

 

WANdisco is the data activation platform for accelerating digital transformation at scale. WANdisco makes infinite data actionable across clouds and enterprises in real time. WANdisco customers unleash the business value of the cloud with zero downtime, data loss, or disruption to fuel AI and machine learning, create new services, and transform businesses. For more information about WANdisco, visit www.wandisco.com.www.wandisco.com

 

Notification and public disclosure of transactions by person discharging managerial responsibilities ("PDMR") and persons closely associated with them.

 1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Karl Monaghan

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

WANdisco plc

b)

LEI

213800Y1A75RSC698O04

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

ISIN: JE00B6Y3DV84

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

455.3p

4,390

 

d)

Aggregated information

-

Aggregated volume

-

Price

 

 

N/A

N/A

e)

Date of the transaction

20 October 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

 

 

 

 

 1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Rosena Monaghan (spouse of Non-Executive Director)

2

Reason for the notification

a)

Position/status

PCA of Karl Monaghan (Non-Executive Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

WANdisco plc

b)

LEI

213800Y1A75RSC698O04

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

ISIN: JE00B6Y3DV84

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

454.75p

4,395

 

d)

Aggregated information

-

Aggregated volume

-

Price

 

 

N/A

N/A

e)

Date of the transaction

20 October 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGMUUUPPGAC
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.